VANGELISTA, LUCA
 Distribuzione geografica
Continente #
EU - Europa 389
NA - Nord America 306
AS - Asia 219
AF - Africa 1
OC - Oceania 1
Totale 916
Nazione #
IE - Irlanda 330
US - Stati Uniti d'America 304
CN - Cina 172
SG - Singapore 44
FI - Finlandia 23
IT - Italia 14
DE - Germania 12
CA - Canada 2
GB - Regno Unito 2
KZ - Kazakistan 2
NL - Olanda 2
PL - Polonia 2
SE - Svezia 2
AU - Australia 1
EG - Egitto 1
FR - Francia 1
JP - Giappone 1
RU - Federazione Russa 1
Totale 916
Città #
Dublin 330
Boardman 82
Ashburn 74
Shanghai 45
Jacksonville 40
Nanjing 38
Singapore 35
Helsinki 23
Nanchang 22
Princeton 15
New York 14
Lawrence 13
Hebei 12
Tianjin 11
Washington 10
Shenyang 9
Wilmington 9
Jiaxing 7
Hangzhou 6
Seattle 6
Beijing 5
Changsha 5
Imbersago 5
Medford 4
Phoenix 4
Ann Arbor 3
Chandler 3
West Jordan 3
Astana 2
Borås 2
Calgary 2
Frankfurt am Main 2
London 2
Norwalk 2
Orange 2
Warsaw 2
Dallas 1
Damietta 1
Falkenstein 1
Fayetteville 1
Friesland 1
Fuzhou 1
Guangzhou 1
Los Angeles 1
Ningbo 1
Paris 1
Pavia 1
Redwood City 1
Rome 1
Santa Clara 1
Tokiwa 1
Zhengzhou 1
Totale 865
Nome #
The elastic I-band region of titin is assembled in a "modular" fashion by weakly interacting Ig-like domains 32
Bip 1, a monoclonal antibody with specificity for the major birch pollen allergen Bet v 1, modulates IgE binding to the allergen 31
Calcium-binding allergens: From plants to man 31
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments - Candidates for a novel form of specific immunotherapy 29
Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5 27
Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from timothy grass (Phleum pratense) pollen 26
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1 26
Division of the major birch pollen allergen, Bet v 1, into two non-anaphylactic fragments 25
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: Candidates for specific immunotherapy 25
Molecular and immunological characterization of carp parvalbumin, a major fish allergen 25
Molecular Characterization of Bip 1, a Monoclonal Antibody That Modulates IgE Binding to Birch Pollen Allergen, Bet v 1 24
Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: Structural basis for calcium-modulated IgE recognition 24
Purification, biochemical, and immunological characterisation of a major food allergen: Different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbumin 23
AllergoOncology – the impact of allergy in oncology: EAACI position paper 22
B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy 20
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer 19
The immunoglobulin-like modules C epsilon 3 and alpha 2 are the minimal units necessary for human IgE-Fc epsilon RI interaction 19
Analysis of the localization of STE6/CFTR chimeras in a Saccharomyces cerevisiae model for the cystic fibrosis defect CFTRΔF508 18
A minimal receptor-Ig chimera of human FcεRI α-chain efficiently binds secretory and membrane IgE 17
An antitumor cellular vaccine based on a mini-membrane IgE 17
Cutting edge: IgE plays an active role in tumor immunosurveillance in mice 17
NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE 17
Effects of omalizumab on basophils: Potential biomarkers in asthma and chronic spontaneous urticaria 16
Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5-CCR5 axis 16
AllergoOncology: Microbiota in allergy and cancer—A European Academy for Allergy and Clinical Immunology position paper 16
In search of a vaccine for mouse allergy: Significant reduction of mus m 1 allergenicity by structure-guided single-point mutations 16
Current progress in the understanding of IgE-FcεRI interaction 16
A molecular model of type I allergy: Identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcεRI interaction and reacts with receptor-bound IgE 16
AllergoOncology: The role of IgE-mediated allergy in cancer 16
NON-ANAPHYLACTIC FORMS OF ALLERGENS AND THEIR USE 16
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity 15
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: Molecular, immunological, and structural characterization of the epitope-containing domain 15
Critical role of the N-loop and β1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity 15
Staphylococcus aureus infection and persistence in chronic rhinosinusitis: Focus on leukocidin ED 15
Functionalized etched tilted fiber Bragg grating aptasensor for label-free protein detection 14
Calcium-dependent immunoglobulin E recognition of the apo- and calcium- bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7 13
Ultralow Limit Detection of Soluble HER2 Biomarker in Serum with a Fiber-Optic Ball-Tip Resonator Assisted by a Tilted FBG 13
An in vitro model for the Allergen-IgE-FcεRI interaction 13
Editorial: CCR5: A receptor at the center stage in infection 12
Antitumor IgE adjuvanticity: Key role of FcεRI 12
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants 12
Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides 11
Picomolar detection of thrombin with fiber-optic ball resonator sensor using optical backscatter reflectometry 10
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses 10
Rational Engineering of a Sub-Picomolar HIV-1 Blocker 10
Membrane immunoglobulins are stabilized by interchain disulfide bonds occurring within the extracellular membrane-proximal domain 10
Rational design of novel HIV-1 entry inhibitors by RANTES engineering 10
The expanding therapeutic perspective of CCR5 blockade 10
Unreliable measurement of basophil maximum leukotriene release with the Bühlmann CAST 2000 enzyme-linked immunosorbent assay kit 9
Ig modules as discrete structural units to exploit functional and structural aspects of Ig-like receptors 9
IgE as Adjuvant in Tumor Vaccination 9
Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES 9
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers 9
Structural Studies on the Zinc‐endopeptidase Light Chain of Tetanus Neurotoxin 8
Efficient folding of the FcεRI α-chain membrane-proximal domain D2 depends on the presence of the N-terminal domain D1 8
Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis 8
Membrane IgE binds and activates FcεRI in an antigen-independent manner 8
Role and redirection of IgE against cancer 8
Perspectives on Assembling Coronavirus Spikes on Fiber Optics to Reveal Broadly Recognizing Antibodies and Generate a Universal Coronavirus Detector 8
Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4 7
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers 7
Modified microbiota for microbicide drug delivery 7
Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential 6
Totale 982
Categoria #
all - tutte 8.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 1 0 0 0 9 0 0
2020/202120 0 0 0 0 0 0 2 9 0 9 0 0
2021/202232 0 0 0 0 0 0 0 1 2 0 10 19
2022/2023409 22 0 0 0 0 0 0 0 376 3 8 0
2023/2024236 23 8 10 20 24 71 31 10 4 8 5 22
2024/2025126 23 68 1 8 26 0 0 0 0 0 0 0
Totale 982